Andrea Bloomquist - Sleep Number Senior Vice President Chief Product Officer
| SL2 Stock | EUR 14.30 1.00 7.52% |
Insider
Andrea Bloomquist is Senior Vice President Chief Product Officer of Sleep Number Corp since 2012.
| Age | 53 |
| Tenure | 12 years |
| Phone | 763 551 7000 |
| Web | https://www.sleepnumber.com |
Andrea Bloomquist Latest Insider Activity
Tracking and analyzing the buying and selling activities of Andrea Bloomquist against Sleep Number stock is an integral part of due diligence when investing in Sleep Number. Andrea Bloomquist insider activity provides valuable insight into whether Sleep Number is net buyers or sellers over its current business cycle. Note, Sleep Number insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sleep Number'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Andrea Bloomquist over six months ago Disposition of 818 shares by Andrea Bloomquist of Sleep Number at 13.53 subject to Rule 16b-3 |
Sleep Number Management Efficiency
The company has return on total asset (ROA) of 0.0453 % which means that it generated a profit of $0.0453 on every $100 spent on assets. This is way below average. Sleep Number's management efficiency ratios could be used to measure how well Sleep Number manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | INSIDER Age | ||
| Kazuya Murakami | Sekisui Chemical Co | 57 | |
| Futoshi Kamiwaki | Sekisui Chemical Co | 63 | |
| Toshiyuki Kamiyoshi | Sekisui Chemical Co | 62 | |
| Katsunori Mukai | Sekisui Chemical Co | N/A | |
| Ikusuke Shimizu | Sekisui Chemical Co | 59 | |
| Naoko Fukutomi | Sekisui Chemical Co | N/A | |
| Keita Kato | Sekisui Chemical Co | 65 | |
| Tatsuya Nishida | Sekisui Chemical Co | N/A | |
| Meiko Koga | Sekisui Chemical Co | N/A | |
| Yoshiyuki Hirai | Sekisui Chemical Co | 60 | |
Management Performance
| Return On Asset | 0.0453 |
Sleep Number Corp Leadership Team
Elected by the shareholders, the Sleep Number's board of directors comprises two types of representatives: Sleep Number inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sleep. The board's role is to monitor Sleep Number's management team and ensure that shareholders' interests are well served. Sleep Number's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sleep Number's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kathleen Nedorostek, Independent Director | ||
| Melissa Barra, Senior Vice President Chief Strategy and Customer Relationship Officer | ||
| Stephen Gulis, Independent Director | ||
| David Callen, Chief Financial Officer, Senior Vice President | ||
| Shelly Ibach, President, Chief Executive Officer, Director | ||
| Joel Laing, Treasurer Fin | ||
| Barbara Matas, Independent Director | ||
| Patricia Dirks, Chief Human Resource Officer, Senior Vice President | ||
| Daniel Alegre, Independent Director | ||
| Samuel Hellfeld, Senior Vice President and Chief Legal and Risk Officer and Secretary | ||
| David Schwantes, Investor Fin | ||
| Brenda Lauderback, Independent Director | ||
| Kevin Brown, Senior Vice President Chief Marketing Officer | ||
| JeanMichel Valette, Non-Executive Independent Chairman of the Board | ||
| Michael Harrison, Independent Director | ||
| Joseph Saklad, Chief VP | ||
| Hunter Saklad, Senior Vice President, Chief Information Officer | ||
| Andrea Bloomquist, Senior Vice President Chief Product Officer | ||
| Deborah Kilpatrick, Independent Director |
Sleep Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sleep Number a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0453 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.4 B | |||
| Shares Outstanding | 22.01 M | |||
| Shares Owned By Insiders | 4.72 % | |||
| Shares Owned By Institutions | 95.28 % | |||
| Price To Earning | 5.79 X | |||
| Price To Sales | 0.27 X | |||
| Revenue | 2.11 B |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Sleep Stock
When determining whether Sleep Number Corp is a strong investment it is important to analyze Sleep Number's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sleep Number's future performance. For an informed investment choice regarding Sleep Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sleep Number Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.